General Information of Drug (ID: DMC7B1B)

Drug Name
BMS-986403
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [1]
Cross-matching ID
TTD ID
D3SP2U

References

1 ClinicalTrials.gov (NCT05244070) A Phase 1, Multicenter, Open-label Study of BMS-986403 in Subjects With Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). U.S.National Institutes of Health.